Gene Expression Profiling of H9c2 Myoblast Differentiation towards a Cardiac-Like Phenotype

PLoS One. 2015 Jun 29;10(6):e0129303. doi: 10.1371/journal.pone.0129303. eCollection 2015.

Abstract

H9c2 myoblasts are a cell model used as an alternative for cardiomyocytes. H9c2 cells have the ability to differentiate towards a cardiac phenotype when the media serum is reduced in the presence of all-trans-retinoic acid (RA), creating multinucleated cells with low proliferative capacity. In the present study, we performed for the first time a transcriptional analysis of the H9c2 cell line in two differentiation states, i.e. embryonic cells and differentiated cardiac-like cells. The results show that RA-induced H9c2 differentiation increased the expression of genes encoding for cardiac sarcomeric proteins such as troponin T, or calcium transporters and associated machinery, including SERCA2, ryanodine receptor and phospholamban as well as genes associated with mitochondrial energy production including respiratory chain complexes subunits, mitochondrial creatine kinase, carnitine palmitoyltransferase I and uncoupling proteins. Undifferentiated myoblasts showed increased gene expression of pro-survival proteins such as Bcl-2 as well as cell cycle-regulating proteins. The results indicate that the differentiation of H9c2 cells lead to an increase of transcripts and protein levels involved in calcium handling, glycolytic and mitochondrial metabolism, confirming that H9c2 cell differentiation induced by RA towards a more cardiac-like phenotype involves remodeled mitochondrial function. PI3K, PDK1 and p-CREB also appear to be involved on H9c2 differentiation. Furthermore, complex analysis of differently expressed transcripts revealed significant up-regulation of gene expression related to cardiac muscle contraction, dilated cardiomyopathy and other pathways specific for the cardiac tissue. Metabolic and gene expression remodeling impacts cell responses to different stimuli and determine how these cells are used for biochemical assays.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blotting, Western
  • Cell Differentiation* / drug effects
  • Cell Line
  • Cell Shape / drug effects
  • Gene Expression Profiling*
  • Gene Expression Regulation / drug effects
  • Metabolic Networks and Pathways / drug effects
  • Metabolic Networks and Pathways / genetics
  • Myoblasts, Cardiac / cytology*
  • Phenotype
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Rats
  • Signal Transduction / drug effects
  • Signal Transduction / genetics
  • Tretinoin / pharmacology

Substances

  • RNA, Messenger
  • Tretinoin

Grants and funding

The present work was supported by the Foundation for Science and Technology, research grants PTDC/SAU-TOX/110952/2009, PTDC/SAU-TOX/117912/2010 and PTDC/DTP-FTO/1180/2012 to PJO, and PEst-C/SAU/LA0001/2013-2014 to the CNC, co-funded by FEDER/Compete and National Budget. SPP is supported by a PhD fellowship from the Foundation for Science and Technology (SFRH/BD/64247/2009). The work was also supported by QREN project #4832 ”Stem cell-based platforms for Regenerative and Therapeutic Medicine” reference CENTRO-07-ST24-FEDER-002008. Ana Branco and Susana Pereira were supported by Ph.D. fellowships SFRH/BD/41384/2007 and SFRH/BD/64247/2009, respectively. Oleg Gusev and Albert A. Rizvanov were supported by Program of Competitive Growth of Kazan Federal University. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.